CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: Phase III Study of ASP2151 in Herpes Simplex Patients [Phase 3]
Summary
Phase III trial of ASP2151 for herpes simplex infection has completed, with results posted on 2024-10-09.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maruho Co., Ltd. | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2024-10-09